Clinical resource
Respiratory non-small cell lung cancer definitive stereotactic EBRT central tumours (eviQ ID 4018)
eviQ, Cancer Institute NSW
DoseLab summary
Endorsed eviQ protocol for central lung SABR. DoseLab's five-fraction column reproduces selected values from its organs-at-risk table, keeping eviQ's citation for each. Check the live page for the current version.
Why this is useful
The central-tumor counterpart: constraints for 50 Gy in 5 fractions (largely from RTOG 0813) and 60 Gy in 8 fractions, each footnoted to its source.
Reference details
- Title
- Respiratory non-small cell lung cancer definitive stereotactic EBRT central tumours (eviQ ID 4018)
- Authors / organization
- eviQ, Cancer Institute NSW
- Publication / protocol
- eviQ Radiation Oncology protocol 4018
- Version
- v.3 — last reviewed 16 March 2023; review due 30 June 2027
- Year
- 2023
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- SBRT, Dose Constraints, Central tumors, Protocols
- Fractionation context
- SBRT: 50 Gy/5 fx, 60 Gy/8 fx
- Last reviewed by DoseLab
- 2026-09-22